Long term, prospective, observational cohort study evaluating the safety profile in patients with highly active relapsing multiple sclerosis (RMS) newly started on cladribine tablets − CLARION

ENCePP Code of conduct

Yes

Data sources

• Data source(s), other:
  • Multiple sclerosis management system 3 Dimension, Germany; • Italian multiple sclerosis and related disorders Registry; • MSBase: Australia, Belgium, Canada, Croatia, Kuwait, Lebanon, the Netherlands and Turkey; • The national healthcare and MS registers in Denmark, Finland, Norway, and Sweden; • The Swiss MS Cohort (Switzerland); • US DOD
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Disease registry

  Electronic healthcare records (EHR)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No

Procedures

No information provided.